drugset / Trial / NCT00789165
Empiric Quinidine for Asymptomatic Brugada Syndrome
Non-randomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to determine if quinidine therapy (not guided by the results of electrophysiologic studies) will reduce the long-term risk of arrhythmic events in asymptomatic Brugada Syndrome.
Timeline
- Start
- 2009-12
- Primary completion
- 2020-02
- Completion
- 2020-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Quinidine | Small molecule | 600 mg | — |
| Subject | Quinidine | Small molecule | 900 mg | — |